DAD1

Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 · P61803 · DAD1 on Sugi Atlas →

0 patent compounds predicted against DAD1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DAD1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients PHASE2ENROLLING_BY_INVITATION
24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG PHASE2COMPLETED
A Study of GlcNAc on Tear Production in NGLY1-CDDG PHASE2ACTIVE_NOT_RECRUITING
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis PHASE1/PHASE2RECRUITING
The Effect of Triheptanoin on Fatty Acid Oxidation and Exercise Tolerance in Patients With Glycogenoses PHASE2COMPLETED
Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis PHASE1/PHASE2ACTIVE_NOT_RECRUITING
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer PHASE2UNKNOWN
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases PHASE1COMPLETED
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation nanCOMPLETED
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta nanRECRUITING
Glycosylation in Patients With Galactosaemia nanCOMPLETED
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia nanRECRUITING
Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects nanUNKNOWN
The Natural History of Alpha-Mannosidosis nanCOMPLETED
Efficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV Clearance nanUNKNOWN
Biomarker for Mannosidosis Disease (BioMannosidosis) nanWITHDRAWN
The Natural History of Sialidosis Type I nanRECRUITING
Registry Gangliosidoses nanUNKNOWN
GNAO1 Natural History Study nanUNKNOWN
Biomarker for Hurler Disease (BioHurler) nanWITHDRAWN
Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2) nanWITHDRAWN
Evaluation of Brain Dysfunction in Patients with Duchene Muscular Dystrophy nanNOT_YET_RECRUITING
Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease nanCOMPLETED
Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children nanRECRUITING
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
A Study Measuring Substances Potentially Indicating Bone Problems in Adults With Type 1 Gaucher Condition nanCOMPLETED
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Biomarker for Farber Disease (BioFarber) nanWITHDRAWN

Related proteins — ESM-2 sequence neighbours (a DAD1 binder may also engage these)

ProteinNameSimilarity
P61805 1.000 P61805 →
Q29036 1.000 Q29036 →
Q5RBB4 1.000 Q5RBB4 →
Q5E9C2 1.000 Q5E9C2 →
P61804 1.000 P61804 →
P61806 1.000 P61806 →
P46967 1.000 P46967 →
Q9ZRA3 0.999 Q9ZRA3 →
O13113 0.998 O13113 →
Q9SME9 0.998 Q9SME9 →
Q8I7Z2 0.997 Q8I7Z2 →
O65085 0.996 O65085 →
O22622 0.995 O22622 →
Q9VLM5 0.994 Q9VLM5 →
Q9SME8 0.993 Q9SME8 →
Q39080 0.992 Q39080 →
Q9SMC4 0.991 Q9SMC4 →
A2XSY1 0.991 A2XSY1 →
Q0JDK9 0.991 Q0JDK9 →
O24060 0.991 O24060 →
P52872 0.991 P52872 →
Q9M3T9 0.991 Q9M3T9 →
Q9ZWQ7 0.988 Q9ZWQ7 →
B9TRX0 0.978 B9TRX0 →
Q5PSV5 0.978 Q5PSV5 →
Q3SYT0 0.977 Q3SYT0 →
Q5ZJD9 0.977 Q5ZJD9 →
O15243 0.976 O15243 →
B3Y064 0.976 B3Y064 →
Q1HQF8 0.975 Q1HQF8 →